Eva J Brandt

Title: Eva J Brandt: Innovator in Radioimmunoassay Technology

Introduction

Eva J Brandt is a notable inventor based in Ellisville, MO (US). She has made significant contributions to the field of immunology, particularly through her innovative work in radioimmunoassay techniques. Her dedication to advancing scientific knowledge has led to the development of a patented method that enhances the detection of specific antigens.

Latest Patents

Eva J Brandt holds a patent for her invention titled "Radioimmunoassay of MIF." This method is designed to detect the presence of migration inhibitory factor (MIF) in a test solution. The process involves reacting a test solution containing an unknown amount of MIF antigen with a known amount of radiolabeled MIF antigen and antibodies to MIF. The resulting immune complex is then precipitated and measured for its radioactive content. This innovative approach utilizes antibodies produced by immunizing animals with MIF antigen obtained from human lymphocytes grown under tissue culture conditions. Eva's patent represents a significant advancement in the field of immunological assays.

Career Highlights

Eva J Brandt has had a distinguished career, working at Monsanto Company, where she has applied her expertise in immunology and biotechnology. Her work has not only contributed to the scientific community but has also had practical applications in various fields, including medical diagnostics and research.

Collaborations

Eva has collaborated with several professionals in her field, including her coworker Samuel S Asculai. These collaborations have fostered an environment of innovation and have led to further advancements in the technologies related to her patents.

Conclusion

Eva J Brandt is a pioneering inventor whose work in radioimmunoassay technology has made a lasting impact on the field of immunology. Her innovative methods continue to influence research and diagnostics, showcasing her significant contributions to science.